Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy

NCT02790242 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT02790242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02790242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy
Lead sponsor
Columbia University
Phase
Observational
Overall status
Terminated
Start date
November 30, 2013
Completion date
February 11, 2020
Enrollment
1,089 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cardiogenic shock, heart failure